GlassScriptPhysician profile
Javed I Memon
NPI 1447780564
$3,552.09
in general payments reported to CMS, 2019-2025
8 companies · $73.30 in 2025
The $73.30 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.58 · 2021: $51.39 · 2022: $17.32 · 2023: $14.57 · 2024: $3,367 · 2025: $73.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $732 · Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $731.62 |
| Food and Beverage | $223.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,341.49 | 2024 | |
| United Therapeutics Corporation | $51.39 | 2021 | |
| Verona Pharma, INC. | $46.57 | 2025 | Ohtuvayre |
| Astrazeneca Pharmaceuticals LP | $42.76 | 2022-2024 | Airsupra |
| Genzyme Corporation | $26.73 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.77 | 2020 | |
| Glaxosmithkline, LLC. | $14.57 | 2023 | Arexvy |
| Veran Medical Technologies, INC. | $5.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javed Memon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.